header ads

We're raising our Eli Lilly price target — what a difference a quarter makes

The drugmaker posted a strong third quarter, driven by sales of its popular GLP-1 medications

from US Top News and Analysis https://ift.tt/3eYKF2P
via IFTTT

Post a Comment

0 Comments